Rapamycin inhibits human renal epithelial cell proliferation: Effect on cyclin D3 mRNA expression and stability

Kidney International

Volumn 67, Issue 6, 2005, Pages 2422-2433

  Pallet, Nicolas ^b   Thervet, Eric ^b   Corre, Delphine Le ^b   Knebelmann, Bertrand ^b   Nusbaum, Patrick ^b   Tomkiewicz, Céline ^b   Meria, Paul ^b   Flinois, Jean Pierre ^b   Beaune, Philippe ^b   Legendre, Christophe ^b   Anglicheau, Dany ^a  

^a INSERM   (France)

^b NONE

Author keywords

Cyclin D; Delayed graft function; p70s6 kinase; Rapamycin; Renal transplantation

Indexed keywords

CYCLIN D3; CYCLIN E; MESSENGER RNA; PHOSPHOTRANSFERASE; RAPAMYCIN; S6 KINASE; CYCLINE; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; EPITHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY EPITHELIUM; KIDNEY TRANSPLANTATION; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA STABILITY; WESTERN BLOTTING; CELL CULTURE; CELL CYCLE S PHASE; CYTOLOGY; GENETICS; KIDNEY; METABOLISM;

CELL PROLIFERATION; CELLS, CULTURED; CYCLINS; EPITHELIAL CELLS; G1 PHASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; PHOSPHORYLATION; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA STABILITY; RNA, MESSENGER; S PHASE; SIROLIMUS;

EID: 23044515582     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00350.x     Document Type: Article

References (54)

1. JOHNSON RW, KREIS H, OBERBAUER R, et al: Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation 72:777-786, 2001
2. SEHGAL SN: Sirolimus: Its discovery, biological properties, and mechanism of action. Transplant Proc 35:S7-S14, 2003
3. SONENBERG N, GINGRAS AC: The mRNA 5′ cap-binding protein eIF4E and control of cell growth. Curr Opin Cell Biol 10:268-275, 1998
4. SCHMELZLE T, HALL MN: TOR, a central controller of cell growth. Cell 103:253-262, 2000
5. HASHEMOLHOSSEINI S, NAGAMINE Y, MORLEY SJ, et al: Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J Biol Chem 273:14424-14429, 1998
6. DECKER T, HIPP S, RINGSHAUSEN I, et al: Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin. Blood 101:278-285, 2003
7. KAWAMATA S, SAKAIDA H, HORI T, et al: The upregulation of p27Kip1 by rapamycin results in G1 arrest in exponentially growing T-cell lines. Blood 91:561-569, 1998
8. GEDDES CC, WOO YM, JARDINE AG: The impact of delayed graft function on the long-term outcome of renal transplantation. J Nephrol 15:17-21, 2002
9. SMITH KD, WRENSHALL LE, NICOSIA RF, et al: Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J Am Soc Nephrol 14:1037-1045, 2003
10. MCTAGGART RA, GOTTLIEB D, BROOKS J, et al: Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant 3:416-423, 2003
11. DAVIS C: Sirolimus delays renal allograft recovery. Am J Transplant 3:363-365, 2003
12. HUMES HD, MACKAY SM, FUNKE AJ, et al: Acute renal failure: Growth factors, cell therapy, and gene therapy. Proc Assoc Am Physicians 109:547-557, 1997
13. WITZGALL R, BROWN D, SCHWARZ C, BONVENTRE JV: Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93:2175-2188, 1994
14. TANG S, LEUNG JC, ABE K, et al: Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 111:515-527, 2003
15. DETRISAC CJ, SENS MA, GARVIN AJ, et al: Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int 25:383-390, 1984
16. JOLY D, MOREL V, HUMMEL A, et al: Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: Role in increased cell adhesion and migration. Am J Pathol 163:1791-1800, 2003
17. HELBERT MF, DAUWE SE, DE BROE ME: Flow cytometric immunodissection of the human distal tubule and cortical collecting duct system. Kidney Int 59:554-564, 2001
18. BAKKER RC, VAN KOOTEN C, VAN DE LAGEMAAT-PAAPE ME, et al: Renal tubular epithelial cell death and cyclosporin A. Nephrol Dial Transplant 17:1181-1188, 2002
19. LEIS M, MARSCHALL M, STAMMINGER T: Downregulation of the cellular adhesion molecule Thy-1 (CD90) by cytomegalovirus infection of human fibroblasts. J Gen Virol 85:1995-2000, 2004
20. PHILLIPS AO, STEADMAN R, TOPLEY N, WILLIAMS JD: Elevated D-glucose concentrations modulate TGF-beta 1 synthesis by human cultured renal proximal tubular cells. The permissive role of platelet-derived growth factor. Am J Pathol 147:362-374, 1995
21. ZANDOMENI R, WEINMANN R: Inhibitory effect of 5,6-dichloro-1-beta-D- ribofuranosylbenzimidazole on a protein kinase. J Biol Chem 259:14804-14811, 1984
22. GRUMMT I: Regulation of mammalian ribosomal gene transcription by RNA polymerase I. Prog Nucleic Acid Res Mol Biol; 62:109-154, 1999
23. -ΔΔCT method. Method 25:402-408, 2001
24. MA Y, YUAN J, HUANG M, et al: Regulation of the cyclin D3 promoter by E2F1. J Biol Chem 278:16770-16776, 2003
25. BERGAMETTI F, SITTERLIN D, TRANSY C: Turnover of hepatitis B virus X protein is regulated by damaged DNA-binding complex. J Virol 76:6495-6501, 2002
26. HELIN K, HARLOW E, FATTAEY A: Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 13:6501-6508, 1993
27. LIEBERTHAL W, FUHRO R, ANDRY CC, et al: Rapamycin impairs recovery from acute renal failure: Role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 281:F693-706, 2001
28. SHANKLAND SJ, WOLF G: Cell cycle regulatory proteins in renal disease: Role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 278:F515-529, 2000
29. SHEPHERD PR, NAVE BT, O'RAHILLY S: The role of phosphoinositide 3-kinase in insulin signalling. J Mol Endocrinol 17:175-184, 1996
30. BROOKS AR, SHIFFMAN D, CHAN CS, et al: Functional analysis of the human cyclin D2 and cyclin D3 promoters. J Biol Chem 271:9090-9099, 1996
31. LANE HA, FERNANDEZ A, LAMB NJ, THOMAS G: p70s6k function is essential for G1 progression. Nature 363:170-172, 1993
32. VINALS F, CHAMBARD JC, POUYSSEGUR J: p70 S6 kinase-mediated protein synthesis is a critical step for vascular endothelial cell proliferation. J Biol Chem 274:26776-26782, 1999
33. MARX SO, JAYARAMAN T, GO LO, MARKS AR: Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 76:412-417, 1995
34. NELSEN CJ, RICKHEIM DG, TUCKER MM, et al: Amino acids regulate hepatocyte proliferation through modulation of cyclin D1 expression. J Biol Chem 278:25853-25858, 2003
35. GREWE M, GANSAUGE F, SCHMID RM, et al: Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70s6K path way in human pancreatic cancer cells. Cancer Res 59:3581-3587, 1999
36. MISAWA A, HOSOI H, TSUCHIYA K, SUGIMOTO T: Rapamycin inhibits proliferation of human neuroblastoma cells without suppression of MycN. Int J Cancer 104:233-237, 2003
37. MUISE-HELMERICKS RC, GRIMES HL, BELLACOSA A, et al: Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem 273:29864-29872, 1998
38. FENG LX, RAVINDRANATH N, DYM M: Stem cell factor/c-kit upregulates cyclin D3 and promotes cell cycle progression via the phosphoinositide 3-kinase/p70 S6 kinase pathway in spermatogonia. J Biol Chem 275:25572-25576, 2000
39. TURNER JM: IL-2-dependent induction of G1 cyclins in primary T cells is not blocked by rapamycin or cyclosporin A. Int immunol 5:1199-1209, 1993
40. KENERSON HL, AICHER LD, TRUE LD, YEUNG RS: Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. Cancer Res 62:5645-5650, 2002
41. EKHOLM SV, REED SI: Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 12:676-684, 2000
42. SHERR CJ: Mammalian G1 cyclins. Cell 73:1059-1065, 1993
43. ALBIG AR, DECKER CJ: The target of rapamycin signaling pathway regulates mRNA turnover in the yeast Saccharomyces cerevisiae. Mol Biol Cell 12:3428-3438, 2001
44. BANHOLZER R, NAIR AP, HIRSCH HH, et al: Rapamycin destabilizes interleukin-3 mRNA in autocrine tumor cells by a mechanism requiring an intact 3′ untranslated region. Mol Cell Biol 17:3254-3260, 1997
45. GHOSH P, BUCHHOLZ MA, YANO S, et al: Effect of rapamycin on the cyclosporin A-resistant CD28-mediated costimulatory pathway. Blood 99:4517-4524, 2002
46. CHEN CY, SHYU AB: AU-rich elements: Characterization and importance in mRNA degradation. Trends Biochem Sci 20:465-470, 1995
47. JEFFERIES HB, FUMAGALLI S, DENNIS PB, et al: Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k. EMBO J 16:3693-3704, 1997
48. ROSENTHAL JT, DANOVITCH GM, WILKINSON A, ETTENGER RB: The high cost of delayed graft function in cadaveric renal transplantation. Transplantation 51:1115-1118, 1991
49. MARCEN R, OROFINO L, PASCUAL J, et al: Delayed graft function does not reduce the survival of renal transplant allografts. Transplantation 66:461-466, 1998
50. Woo YM, JARDINE AG, CLARK AF, et al: Early graft function and patient survival following cadaveric renal transplantation. Kidney Int 55:692-699, 1999
51. BOOM H, MALLAT MJ, DE FIJTER JW, et al: Delayed graft function influences renal function, but not survival. Kidney Int 58:859-866, 2000
52. PROMMOOL S, JHANGRI GS, COCKFIELD SM, HALLORAN PF: Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol 11:565-573, 2000
53. MCCAULEY J: The nephrotoxicity of FK506 as compared with cyclosporine. Curr Opin Nephrol Hypertens 2:662-669, 1993
54. KAHAN BD: Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: A randomised multicentre study. The Rapamune US Study Group. Lancet 356:194-202, 2000